As Global Head of Development Franchise Ophth...
Dorit B. Donoviel, PhD, Deputy Chief Scientis...
At the recent Ophthalmology Innovation Summit...
Jeff George, President & Global Head of Alcon...
Prior to starting Ocular Therapeutix, Amar Sa...
OIS stalwart Jack Holladay, MD shares details...
The FDA turned away Alimera Sciences’ bid t...
TearScience CEO Tim Willis discusses the emer...
OIS co-chair Cunningham delivers a high altit...